Inflammatory myofibroblastic tumors (IMTs) are intermediate-grade tumors of the bladder that commonly recur but rarely spread to other parts of the body, and this study reviews their clinical presentation and management options.
The study analyzed 75 case reports, finding that most patients are around 36 years old, often present with hematuria, and the majority of tumors are anaplastic lymphoma kinase positive; various surgical approaches were used for treatment.
Complete surgical removal of the tumor is essential for effective management, and distinguishing IMTs from other tumor types like sarcoma is critical for achieving the best patient outcomes.